May 13, 2022 | Uncategorized
Recording-artist/songwriter/producer Dina Fanai AKA AVALONA, released Legacy today across all platforms Legacy was written as an anthem for patients with Charcot-Marie-Tooth disease (CMT), one of the world’s most common inherited neurological diseases. CMT causes...
Dec 31, 2021 | Uncategorized
2021 has been a banner year for progress in CMT drug development, much of which has been possible because of your partnership with the CMT Research Foundation – thank you! Despite the challenges presented by a global pandemic, we can be proud of all that we were able...
Jul 16, 2021 | Uncategorized
To read the full transcription click here.
Mar 25, 2020 | CMT Research Updates, Research news, Uncategorized
Two CMT Research Foundation Scientific Advisory Board members make a new discovery Congratulations to our Scientific Advisory Board members Drs. Charlotte Sumner and William Motley on their recent publication identifying a new gene implicated in CMT2. Genetic...
Mar 9, 2020 | CMT Research Updates, CMTRF Funded Research, Drug Development, Uncategorized
Gene Therapy for Axonal Neuropathies By Grace Pavlath, PhD I’ve written recently about gene therapy approaches in development for CMT1A, a form of CMT that affects the myelin sheath of nerves. There is also robust research to develop gene therapies for axonal forms...
Jan 7, 2020 | CMT Research Updates, Press Releases, Research news, Uncategorized
A Review of Clinical Trial Readiness for CMT BY CMT RESEARCH FOUNDATION’S SCIENTIFIC ADVISORY BOARD MEMBER DR. ALEXANDER ROSSOR Read the full paper In this issue of Brain Research, Mike Shy, Mary Reilly and I summarize the current array of outcome measures for...
Important Research News Announcements